Published in Ann Rheum Dis on December 01, 2003
The mosaic of "seronegative" antiphospholipid syndrome. J Immunol Res (2014) 0.87
Severe limb necrosis: primary thrombotic microangiopathy or "seronegative" catastrophic antiphospholipid syndrome? A diagnostic dilemma. Clin Rheumatol (2007) 0.84
Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis. J Autoimmune Dis (2009) 0.83
Isolated IgA anti- β2 glycoprotein I antibodies in patients with clinical criteria for antiphospholipid syndrome. J Immunol Res (2014) 0.82
Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome. Clin Exp Immunol (2012) 0.81
Current treatment of antiphospholipid syndrome: lights and shadows. Nat Rev Rheumatol (2015) 0.80
Hughes syndrome (the antiphospholipid syndrome): a disease of our time. Inflammopharmacology (2010) 0.78
"New" antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome. J Immunol Res (2015) 0.78
Diagnosis of antiphospholipid syndrome in routine clinical practice. Lupus (2012) 0.78
The antiphospholipid syndrome: from pathophysiology to treatment. Clin Exp Med (2016) 0.77
Seronegative antiphospholipid syndrome. Ann Rheum Dis (2004) 0.75
An aspirin responsive non-progressive chronic chorea. J Neurol Neurosurg Psychiatry (2006) 0.75
Familial primary antiphospholipid syndrome: A report of co-occurrence in three Malaysian family members. Eur J Rheumatol (2016) 0.75
Bouquet variety of antiphospholipid antibodies in recurrent pregnancy loss. Cent Eur J Immunol (2014) 0.75
Cerebral venous thrombosis revealing primary sjögren syndrome: report of 2 cases. Case Rep Med (2013) 0.75
Rational Laboratory Diagnostics of Antiphospholipid Antibodies: Anti-Cardiolipin, Anti-β2-Glycoprotein I, Anti-Prothrombin and Anti-Annexin V Antibodies. EJIFCC (2010) 0.75
Antiphospholipid syndrome in Sarawak: real world experience in a developing country. Clin Rheumatol (2014) 0.75
Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients. Clin Rheumatol (2017) 0.75
Complete resolution of a mitral valve vegetation with anticoagulation in seronegative antiphospholipid syndrome. Clin Rheumatol (2008) 0.75
Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances. Nat Rev Rheumatol (2017) 0.75
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet (1983) 6.71
Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) (1983) 5.04
The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. J Rheumatol (2001) 1.35
Hughes syndrome crosses boundaries. Autoimmun Rev (2002) 1.14
Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome. Br J Rheumatol (1998) 1.14
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum (1999) 7.67
Systemic lupus erythematosus. Lancet (2001) 4.18
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus (2003) 3.61
The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) (1989) 3.13
Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1993) 2.88
Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med (1989) 2.23
Minocycline-induced arthritis. Clin Exp Rheumatol (1998) 2.09
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis (2010) 2.05
Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases. Lupus (2009) 1.97
Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Ann Rheum Dis (2004) 1.91
Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus (1998) 1.80
Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol (1996) 1.76
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med (1994) 1.67
Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1999) 1.66
Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. J Rheumatol (1998) 1.54
Up-regulated tissue factor expression in antiphospholipid syndrome. Thromb Haemost (1997) 1.52
Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum (1997) 1.45
Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol (1996) 1.44
Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol. J Thromb Haemost (2005) 1.43
Plasma tumor necrosis factor alpha levels and the -238*A promoter polymorphism in patients with antiphospholipid syndrome. Thromb Haemost (2001) 1.41
Effect of beta 2glycoprotein I and human monoclonal anticardiolipin antibody on the protein S/C4b-binding protein system. Lupus (1997) 1.40
[Anti-phospholipid antibodies]. Rev Clin Esp (1988) 1.39
Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology (Oxford) (2003) 1.38
Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis (2003) 1.38
The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. J Rheumatol (2001) 1.35
Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol (1990) 1.35
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis (2008) 1.28
Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study. Arthritis Rheum (2010) 1.26
Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) (2000) 1.24
Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin Exp Immunol (1991) 1.21
Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus. Lupus (2003) 1.21
Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med (1995) 1.19
The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus (2009) 1.17
Renal artery stenosis in the antiphospholipid (Hughes) syndrome and hypertension. Ann Rheum Dis (2003) 1.14
Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome. Br J Rheumatol (1998) 1.14
The Euro-lupus project: epidemiology of systemic lupus erythematosus in Europe. Lupus (2009) 1.14
The ANCA test: its clinical relevance. Ann Rheum Dis (1990) 1.11
Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome. Arthritis Rheum (1999) 1.11
Thrombocytopenia in the antiphospholipid syndrome. Ann Rheum Dis (1997) 1.09
The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. Br J Rheumatol (1997) 1.07
Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum (2000) 1.05
Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum (1994) 1.05
Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1. Arthritis Rheum (1998) 1.04
Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. Arthritis Rheum (1997) 1.04
Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities. J Thromb Haemost (2012) 1.03
The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost (1998) 1.02
Statins prevent endothelial cell activation induced by antiphospholipid (anti-beta2-glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype. Arthritis Rheum (2001) 1.02
Anticardiolipin antibody. BMJ (1989) 1.01
Allergic disorders in systemic lupus erythematosus. Lupus (1993) 1.00
Prevalence of the antiphospholipid syndrome in primary systemic vasculitis. Ann Rheum Dis (2006) 1.00
BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000. Ann Rheum Dis (2007) 0.99
The systemic lupus erythematosus (SLE) disease autoantigen-calreticulin can inhibit C1q association with immune complexes. Clin Exp Immunol (1997) 0.99
beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum (1994) 0.99
Antiphospholipid syndrome: linking many specialties. Ann Rheum Dis (1989) 0.99
Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol (1993) 0.99
Myocardial infarction and antiphospholipid antibodies in SLE and related disorders. Q J Med (1989) 0.98
Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol (1993) 0.97
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev (2005) 0.97
Anti-endothelial cell antibodies, endothelial proliferation and von Willebrand factor antigen in Behçet's disease. Clin Rheumatol (1995) 0.97
Antiphospholipid antibodies in cerebral ischemia. Stroke (1991) 0.96
Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis (1996) 0.96
Immunological findings in Kawasaki disease: an evaluation in a cohort of Italian children. Clin Exp Rheumatol (1998) 0.96
Laboratory diagnosis and management challenges in the antiphospholipid syndrome. Lupus (2006) 0.95
Pregnancy in granulomatous vasculitis. Ann Rheum Dis (1995) 0.95
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report. Lupus (2003) 0.95
Antiphospholipid antibody tests: spreading the net. Ann Rheum Dis (2005) 0.94
Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmunity (1991) 0.94
Major histocompatibility complex associations with primary antiphospholipid syndrome. Arthritis Rheum (1992) 0.94
Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis. Ann Rheum Dis (1989) 0.94
Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes. Arthritis Rheum (1998) 0.93
The placental bed in pregnancies complicated by primary antiphospholipid syndrome. Placenta (2005) 0.93
Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study. Ann Rheum Dis (2003) 0.93
A need for standardization of the anti-endothelial-cell antibody test. Immunol Today (1995) 0.92
A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol (1996) 0.92
Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus. QJM (1999) 0.92
Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis. Am J Kidney Dis (1992) 0.92
Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome. Ann Rheum Dis (1992) 0.91
Release of calreticulin from neutrophils may alter C1q-mediated immune functions. Biochem J (1997) 0.90
Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide. Ann Rheum Dis (1997) 0.90
Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. Lupus (2003) 0.89
Migraine in Hughes syndrome--heparin as a therapeutic trial? QJM (2001) 0.89
Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases. Am J Gastroenterol (1992) 0.89
Obstetric outcome in systemic lupus erythematosus. Semin Arthritis Rheum (1995) 0.89
Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis (2005) 0.89
Splenectomy for refractory thrombocytopenia in the antiphospholipid syndrome. Rheumatology (Oxford) (1999) 0.89
Non-steroidal anti-inflammatory drugs as a possible cause for reversible infertility. Rheumatology (Oxford) (2000) 0.89
A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo. Br J Dermatol (2001) 0.88
Thrombosis in Churg-Strauss syndrome. Beyond vasculitis? Br J Rheumatol (1996) 0.88
Antiphospholipid antibodies, systemic lupus erythematosus, and non-traumatic metatarsal fractures. Ann Rheum Dis (2004) 0.88
Migraine and stroke in young women. QJM (2000) 0.88
Update on immunotherapy for systemic lupus erythematosus--what's hot and what's not! Rheumatology (Oxford) (2009) 0.88
Low dose methotrexate treatment in adult Still's disease. J Rheumatol (1992) 0.88
Sticky blood and headache. Lupus (2001) 0.88
Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents. Rheumatology (Oxford) (2002) 0.88
Fine specificity of autoantibodies to calreticulin: epitope mapping and characterization. Clin Exp Immunol (2000) 0.88
Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus. Clin Exp Rheumatol (1996) 0.87
Anticardiolipin antibodies in a patient with Crohn's disease and thrombosis. Clin Exp Rheumatol (1992) 0.87